Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis
about
Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2Neural immune pathways and their connection to inflammatory diseasesMolecular mechanisms underlying β-adrenergic receptor-mediated cross-talk between sympathetic neurons and immune cellsBeta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2Regulation of thymocyte positive selection and motility by GIT2.Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.Monocytes/Macrophages control resolution of transient inflammatory pain.Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice.Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling.Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal mice.Beta 2-adrenergic receptor regulation of human neutrophil function is sexually dimorphic.GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain.Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia.Role of myeloid-specific G-protein coupled receptor kinase-2 in sepsis.Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis.G protein-coupled receptor kinases: more than just kinases and not only for GPCRsThe evolving impact of g protein-coupled receptor kinases in cardiac health and diseaseG protein-coupled receptor kinase 6 acts as a critical regulator of cytokine-induced hyperalgesia by promoting phosphatidylinositol 3-kinase and inhibiting p38 signaling.The protein LJM 111 from Lutzomyia longipalpis salivary gland extract (SGE) accounts for the SGE-inhibitory effects upon inflammatory parameters in experimental arthritis model.Desensitization of herpesvirus-encoded G protein-coupled receptors.Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice.Sympathetic modulation of immunity: relevance to disease.Astrocyte GRK2 as a novel regulator of glutamate transport and brain damage.Inhibition of G-Protein βγ Signaling Decreases Levels of Messenger RNAs Encoding Proinflammatory Cytokines in T Cell Receptor-Stimulated CD4(+) T Helper Cells.Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).Molecular Mechanisms Linking Autonomic Dysfunction and Impaired Cardiac Contractility in Critical IllnessProstaglandin E2 affects T cell responses through modulation of CD46 expressionNeuroinflammation and comorbidity of pain and depression.β-Arrestins in the immune systemG protein-coupled receptor kinase 2 moderates recruitment of THP-1 cells to the endothelium by limiting histamine-invoked Weibel-Palade body exocytosis.Adrenergic signaling in heart failure and cardiovascular aging.Role of G protein-coupled receptor kinase 2 in tumoral angiogenesis.Myeloid-specific GPCR kinase-2 negatively regulates NF-κB1p105-ERK pathway and limits endotoxemic shock in miceGrowth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2.Altered sympathetic-to-immune cell signaling via β₂-adrenergic receptors in adjuvant arthritis.G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunitsEndothelial G protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species.G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in mice.
P2860
Q24305064-D27D1B95-E61F-4081-9E78-4C4790FDAB90Q24794997-058C42D7-01AC-46D6-9E01-1FF6D317FA24Q28083146-9FBB084F-BA3F-47CE-B663-81C35BB4F2F5Q28359741-D598E832-A84C-4C42-A2FC-636DC89AED5BQ33568538-0D211E45-52F7-4F5E-B080-615D70BDB315Q33625259-D4EF7587-9F8B-4C2F-8309-C4988B571B93Q33823432-45D854BA-87C4-4773-88C3-FDFEB5D0E2B5Q33890786-6696F69B-6594-4FCF-8D52-53D2C8CB4EBBQ34064133-CB14143A-5E47-494C-AE12-9AC163971531Q34385062-C77176F2-F716-45C2-B6F8-6DD11F5CE79AQ34997832-3341F634-21B4-4A3C-A787-208BB794B92FQ34997837-3F59BAFA-78A0-4FA7-93A6-491185B856AAQ35048442-2C772A5A-8E1C-4D44-BFCE-8959254037A3Q35086498-144233E8-1395-447D-8063-1AA40660DBB2Q35479887-500386C3-E24B-460C-9D46-6D538C673B37Q35586241-05E74569-83D3-44C8-B434-27BBE88C87C1Q35605672-DDBD4949-EB75-480D-BFAC-CA99A1AC2FE2Q35621624-4CDF6039-C9C0-402E-87ED-57CAE8E39D0CQ36000382-2930709D-CDA4-4D82-81BB-F87D0DC0A522Q36071756-EEAA9C89-99D1-4338-9AF3-B45B501AB7E8Q36224586-BC6BD24C-4052-4EDC-BC9B-D02DF55524BCQ36454708-717241EC-E227-47AD-8B5A-BA0E3F0F14CDQ36482911-2018487B-E958-4646-B478-5B74A8EB6536Q36552147-127DAA73-BDA8-48A7-87F2-A74414411DB9Q36774050-0BF3643A-3872-4C46-B8EE-FA14752CA0D7Q36797406-C17936D8-E241-46CC-B432-4B870AD5C81DQ37087686-DDD67CEE-76D0-4AF2-9366-2C6AB8BC8377Q37108942-A7258C31-2700-4534-9DB6-99096C5F4709Q37135949-BD92961B-AEB7-4785-AD2D-C565A24CC5BAQ37432089-45FB647D-C8C5-4E4D-BDB1-06C88FD46AC6Q38114223-D5566434-0067-4619-95A8-B403851D3CCAQ38307746-C20E4323-1D2C-422C-BA05-4E3F3B8EAA53Q38803622-064AD662-3A7F-45EC-B7CC-131AE539AE46Q38866740-8F1011E5-D51C-4E56-9E42-2B19300D2041Q41565044-7E56278E-C9AD-448D-B824-D9ED42133765Q41903711-8B964077-6301-49F2-992F-AC8BE073638CQ41915075-592D17AD-615C-49E0-8172-9351ADCE8642Q42104261-ABD7F02C-7A27-46C6-B593-60E8A70915D7Q42111941-14B8DBB7-D48F-45EB-9B04-6E0B7A22B642Q42263552-16C40861-1F17-465A-9CF8-C11DF21DFE14
P2860
Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Decreased expression and activ ...... ents with rheumatoid arthritis
@ast
Decreased expression and activ ...... ents with rheumatoid arthritis
@en
Decreased expression and activ ...... ents with rheumatoid arthritis
@nl
type
label
Decreased expression and activ ...... ents with rheumatoid arthritis
@ast
Decreased expression and activ ...... ents with rheumatoid arthritis
@en
Decreased expression and activ ...... ents with rheumatoid arthritis
@nl
prefLabel
Decreased expression and activ ...... ents with rheumatoid arthritis
@ast
Decreased expression and activ ...... ents with rheumatoid arthritis
@en
Decreased expression and activ ...... ents with rheumatoid arthritis
@nl
P2093
P1433
P1476
Decreased expression and activ ...... ents with rheumatoid arthritis
@en
P2093
A Kavelaars
C J Heijnen
J W Bijlsma
K L Okihara
M S Lombardi
M Schedlowski
M Van de Pol
R E Schmidt
S Ochsmann
P304
P407
P577
1999-04-01T00:00:00Z